Mon Feb 10 07:20:00 UTC 2025: ## Consistent Patient Monitoring Key to Early Detection of Interstitial Lung Disease in Cancer Patients
**Cranbury, NJ** – Consistent care and close monitoring are crucial for early detection of serious adverse events (AEs) like interstitial lung disease (ILD) in cancer patients, according to Erica S. Doubleday, MS, FNP-C, BSN, RN, Director of APPs Oncology Service Line Hematology and Medical Oncology at Ochsner Health System. Doubleday emphasized the importance of building strong patient relationships to identify subtle changes in symptoms that might indicate ILD.
In an interview, Doubleday highlighted the role of nurses and advanced practice providers (APPs) in consistently monitoring patients across appointments. She stressed that noticing even minor changes, such as increased shortness of breath or decreased pulse oximetry readings, can be key indicators. Utilizing electronic medical records to track trends over time and collaborating with patients’ support systems were also cited as essential strategies for early detection.
Doubleday advised APPs and physicians to pay close attention to patient observations during routine visits, noting that seemingly minor symptoms reported by patients or their companions can point towards developing AEs. She encouraged providers to engage in detailed questioning, probing for nuances that patients may not initially disclose, such as the duration of symptom recovery after exertion.
This focus on consistent, comprehensive patient monitoring underscores the importance of proactive care in minimizing the risk of serious complications in cancer treatment.
First Piper 